Potent antibody immunity to SARS-CoV-2 variants elicited by a third dose of inactivated vaccine

CLINICAL AND TRANSLATIONAL MEDICINE

JOHN WILEY & SONS LTD

1. National Science Fund for Distinguished Young Scholars [82025022]
2. National Natural Science Foundation of China [82002140, 82171752, 82101861]
3. Guangdong Basic and Applied Basic Research Foundation [2021B1515020034, 2019A1515011197, 2021A1515011009, 2020A1515110656]
4. Shenzhen Science and Technology Program [RCYX20200714114700046, JSGG20200207155251653, JSGG20200807171401008, KQTD20200909113758004, JCYJ20190809115617365]